Asklepios Biopharmaceutical Inc.

NC · United States · Reporting entity ID 100001341936

Total reported 2019–2025

$16.4M

#362 of 2,960 reporting companies — 0% of all reported industry payments

$16.4M in general payments across 23 records.

How it breaks down

General payments $16,372,111

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.